90 related articles for article (PubMed ID: 14691579)
1. PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction.
Gorchakova O; Koch W; Mehilli J; von Beckerath N; Schwaiger M; Schömig A; Kastrati A
Thromb Haemost; 2004 Jan; 91(1):141-5. PubMed ID: 14691579
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction.
Sibbing D; von Beckerath O; von Beckerath N; Koch W; Mehilli J; Schwaiger M; Schömig A; Kastrati A
Blood Coagul Fibrinolysis; 2005 Oct; 16(7):511-5. PubMed ID: 16175011
[TBL] [Abstract][Full Text] [Related]
3. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.
Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M
N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737
[TBL] [Abstract][Full Text] [Related]
4. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
Kastrati A; Mehilli J; Dirschinger J; Schricke U; Neverve J; Pache J; Martinoff S; Neumann FJ; Nekolla S; Blasini R; Seyfarth M; Schwaiger M; Schömig A;
Lancet; 2002 Mar; 359(9310):920-5. PubMed ID: 11918909
[TBL] [Abstract][Full Text] [Related]
5. Myocardial salvage after reduced-dose thrombolysis combined with glycoprotein IIb/IIIa blockade versus thrombolysis alone in patients with acute myocardial infarction.
Ndrepepa G; Mehilli J; Schwaiger M; Nekolla S; Schmitt C; Dirschinger J; Schömig A; Kastrati A
J Thromb Thrombolysis; 2004 Jun; 17(3):191-7. PubMed ID: 15353917
[TBL] [Abstract][Full Text] [Related]
6. Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis.
Dibra A; Mehilli J; Dirschinger J; Pache J; Neverve J; Schwaiger M; Schömig A; Kastrati A
J Am Coll Cardiol; 2003 Mar; 41(6):925-9. PubMed ID: 12651035
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of the platelet glycoprotein IIIa Pl(A1/A2) polymorphism in three South African ethnic groups and its effect on platelet function.
Naran NH; Chetty N; Crowther NJ
Thromb Res; 2008; 123(2):316-23. PubMed ID: 18657307
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.
Ndrepepa G; Mehilli J; Schwaiger M; Schühlen H; Nekolla S; Martinoff S; Schmitt C; Dirschinger J; Schömig A; Kastrati A
J Nucl Med; 2004 May; 45(5):725-9. PubMed ID: 15136618
[TBL] [Abstract][Full Text] [Related]
9. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC
Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022
[TBL] [Abstract][Full Text] [Related]
10. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment.
Dibra A; Mehilli J; Schwaiger M; Schühlen H; Bollwein H; Braun S; Neverve J; Schömig A; Kastrati A
Eur Heart J; 2003 Jun; 24(12):1128-33. PubMed ID: 12804927
[TBL] [Abstract][Full Text] [Related]
12. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy.
Dong J; Ndrepepa G; Schmitt C; Mehilli J; Schmieder S; Schwaiger M; Schömig A; Kastrati A
Circulation; 2002 Jun; 105(25):2946-9. PubMed ID: 12081985
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death.
Mikkelsson J; Perola M; Laippala P; Penttilä A; Karhunen PJ
J Am Coll Cardiol; 2000 Oct; 36(4):1317-23. PubMed ID: 11028489
[TBL] [Abstract][Full Text] [Related]
14. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.
Pamukcu B; Oflaz H; Nisanci Y
Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
Mikkelsson J; Perola M; Laippala P; Savolainen V; Pajarinen J; Lalu K; Penttilä A; Karhunen PJ
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2573-8. PubMed ID: 10521390
[TBL] [Abstract][Full Text] [Related]
16. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.
Lopes NH; Pereira AC; Hueb W; Soares PR; Lanz JR; Gersh BJ; de Oliveira S; Cesar LA; Ramires JF; Krieger JE
Am J Cardiol; 2004 Jun; 93(12):1469-72. PubMed ID: 15194015
[TBL] [Abstract][Full Text] [Related]
17. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
[TBL] [Abstract][Full Text] [Related]
18. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
19. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A
Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphism of GPIIIA platelet glycoprotein gene PIA1/A2 compared to plasma hemostasis in myocardial infarction patients].
Tereshchenko SN; Levchuk NN; Drozdov VN; Shaĭkhaev GO; Leont'ev SG; Kirienko AI; Moiseev VS
Ter Arkh; 1999; 71(9):66-70. PubMed ID: 10553630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
